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Background:Many individuals with schizophrenia experience remission of prominent positive symptoms but
continue to experience impairments in real world functioning. Residual negative and depressive symptoms
may have a direct impact on functioning and impair patients' ability to use the cognitive and functional skills
that they possess (competence) in the real world (functional performance).
Methods: One hundred thirty-six individuals (100 men, 36 women) with schizophrenia were classiﬁed as
having primarily positive symptoms, primarily negative symptoms, primarily depressive symptoms, or
undifferentiated symptom proﬁles. Performance based measures of cognition and adaptive and interpersonal
functional competence were used, along with ratings of real world behavior by high contact clinicians. As-
sessments were performed at baseline and at an 18-month follow-up.
Results: The relationships between neurocognition and capacity/performance were not moderated by symp-
tom group ps N .091; neurocognition predicted capacity and performance for all groups ps b .001. The rela-
tionship between adaptive competence and adaptive performance was moderated by symptom group,
ps b .01, such that baseline competence only predicted future performance ratings for participants with pri-
marily positive or undifferentiated symptoms, and not for individuals with primarily negative or depressive
symptoms. This same moderation effect was found on the relationship between interpersonal competence
and interpersonal performance, ps b .002.
Conclusions: Residual negative and depressive symptoms are distinct constructs that impede the use of func-
tional skills in the real world. Depressive symptoms are often overlooked in schizophrenia but appear to be
an important factor that limits the use of functional ability in real world environments.
© 2014 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by/3.0/).1. Introduction
The concept of functional recovery transcends the traditional
medical model of symptom remission (Andreasen et al., 2005) to in-
clude the attainment of meaningful roles in the community (Harvey
& Bellack, 2009). As such, community functioning is an increasingly
important treatment target for schizophrenia. Unfortunately, full
functional recovery is rarely attained and even less frequently
maintained, even after symptoms have remitted (Robinson et al.,
1999; 2004). Profound impairments persist after clinical stabilization
across multiple domains of functioning, including occupational and
academic achievement, interpersonal relationships, and independent
living (Abdallah et al., 2009; Bowie et al., 2008; Green et al., 2004)., Department of Psychology,
ada, K7L 3N6. Tel.: +1 613 533
nc. This is an open access article undeFunctioning can be considered to consist of two distinct constructs:
competence (what one can do under optimal conditions) and perfor-
mance (what one actually does in the real world; Gupta et al., 2012).
Competence, typically indexed by performance on measures of various
cognitive and functional abilities, accounts for a substantial, but still mi-
nority, portion of the variance in performance, typically indexed
through ratings of community behavior by third-party observers. In a
recent report, Gupta et al., (2012) examined this competence-
performance discrepancy and found that both intrinsic (e.g.,
neurocognitive ability, depressive symptoms,motivation) and environ-
mental (e.g., residential and vocational opportunities, hospitalization,
disability rules) factors predict whether an individual under-performs
in the realworld relative to performance on laboratorymeasures of var-
ious functional and cognitive abilities.
Positive and negative symptoms have been consistently found to
be minimally related to functional competence, but they are often
found to be associated with poorer everyday real world performancer the CC BY-NC-ND license (http://creativecommons.org/licenses/by/3.0/).
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ered (e.g., Bowie et al., 2006; 2008; 2010; Leifker et al., 2009;
Sabbag et al., 2012; Smith et al., 2002; Stefanopoulou et al., 2011).
Positive symptoms tend to respond well to pharmaceutical treat-
ment, but approximately 15-20% of people with schizophrenia expe-
rience treatment-resistant negative symptoms (Buchanan, 2007)
that are strongly associated with poor functional outcomes (e.g.,
Herberner & Harrow, 2004; Leifker et al., 2009; Milev et al., 2005;
Sabbag et al., 2012). Depressive symptoms are also important to con-
sider in schizophrenia, and are present in up to 83% of patients at ﬁrst
admission for schizophrenia (Häfner et al., 2005), 40% meeting life-
time criteria for major depression (Harvey et al., in press), and in
any month approximately 35% of patients with schizophrenia pre-
sent with at least one of the core symptoms of depression (an der
Heiden et al., 2005). Patients in the community still experience
symptoms of depression, even after remission of positive symptoms
(Baynes et al., 2000; Pogue-Geile, 1989). These residual depressive
symptoms are overlooked in schizophrenia, yet they may interfere
with everyday task performance (Bowie et al., 2006; 2008; 2010;
Harvey, 2011; Sabbag et al., 2012). Thus, negative and depressive
symptoms provide insight into persistent functional impairment in
spite of positive symptom reduction. Although negative symptoms
are well known to be associated with functional disability, depres-
sive symptoms in schizophrenia have not yet received much atten-
tion in the research literature.
The purpose of this study is to examine the longitudinal moderating
effect of symptomology, particularly depressive symptoms, on the rela-
tionship between cognitive and functional competence with functional
performance in schizophrenia. We examined individuals with four dis-
tinct symptom proﬁles: (1) positive symptoms (with minimal negative
symptoms); (2) negative symptoms (with minimal positive symp-
toms); (3) depressive symptoms (with minimal concurrent positive
or negative symptoms); and (4) undifferentiated symptoms (could
not be classiﬁed into one of the above categories). To our knowledge,
this is the ﬁrst longitudinal study to examine functioning in individuals
with schizophrenia whose negative and positive symptoms were min-
imal and whose only active symptoms were depressive symptoms.
2. Methods
2.1. Participants
People with a diagnosis of either schizophrenia or schizoaffective
disorder (100 men, 36 women) were assessed twice at 18 month in-
tervals. Exclusion criteria included any DSM-IV (American Psychiatric
Association, 1994) Axis I disorder other than schizophrenia or
schizoaffective disorder, a Mini-Mental State Examination (Folstein
et al., 1975) score below 18, Wide Range Achievement Test (WRAT-3;
Wilkinson, 1993) reading equivalent of grade 6 or less, or any medical
illnesses that affect cognitive functioning (e.g., traumatic brain injury,
epilepsy, cerebrovascular accident, multiple sclerosis). A trained
research assistant completed the Comprehensive Assessment of
Symptoms and History (CASH; Andreasen et al., 1992) with each
participant, and a senior clinician conﬁrmed the diagnosis.
2.2. Measures
All participants completed the assessments in a ﬁxed order. All
raters received extensive training and were subject to reevaluations
of their performance every three months. Raters were trained to ade-
quate reliability on symptom ratings yielding intra-class correlation
coefﬁcients (ICC) ranging from .86 to .92.
2.2.1. Symptom assessment
Severity of clinical symptoms was assessed with the Positive
and Negative Syndrome Scale (PANSS; Kay, 1991). Following astructured interview, seven positive symptoms, seven negative
symptoms, and sixteen general aspects of psychopathology were
rated on a 7-point Likert-type scale. Participants also completed
the Beck Depression Inventory, second edition (BDI-II; Beck et al.,
1996) – a self-report measure of depressive symptoms consisting
of 21 questions with response options ranging from 0 (absence of
symptom) to 3 (symptom is severe). In accordance with previous
studies (Bowie et al., 2006; Bowie et al., 2008), the BDI was used in-
stead of the Depression item on the PANSS (PANSS-D) due to the
greater breadth of symptom information obtained (Lindenmayer
et al., 1992). The correlation between the BDI-II and the PANSS-D
in the present sample was r = .51, p b .001.2.2.2. Neurocognition
The following measures of neurocognition were included: Trail-
Making Test Parts A and B (Reitan &Wolfson, 1993); category naming
(animal naming; Spreen & Strauss, 1998); phonological ﬂuency (F, A, S;
Spreen & Strauss, 1998); the Digit Span Distraction Test (DSD;
Oltmanns & Neale, 1975); Rey Auditory Verbal Learning Test (RAVLT;
Morris et al., 1989) learning trials 1 to 5, RAVLT short delay free recall,
and recognition; Wisconsin Card Sorting Test 64-card computerized
version (WCST; Heaton et al., 1993); the Constructional Praxis test
(Morris et al., 1989); and the Wechsler Adult Intelligence Scale, Third
Edition (WAIS-III; Wechsler, 1998) digit span, digit symbol, and
letter-number sequencing subtests. A global cognitive composite was
computed by creating an equally weighted average of all of the cogni-
tivemeasures after eachwas converted into z-scores based on norms in
the instruments' manuals, as we have previously reported (Bowie et al.,
2006, 2008).2.2.3. Performance-based functional capacity
The UCSD Performance-Based Skills Assessment Battery (UPSA;
Patterson et al., 2001a) is designed to assess functional capacity. The
UPSA measures performance in a number of everyday functional do-
mains (e.g., transportation, planning recreation) through the use of
props and standardized skills performance situations. A total UPSA
score is calculated based on the number of correct responses.
The Social Skills Performance Assessment (Patterson et al., 2001b)
is a measure of social skills. After a practice trial, the patients initiate
and maintain a conversation for 3 minutes in each of two situations:
greeting a new neighbor and calling a landlord to request a repair for
a leak. These sessions were audiotaped and scored by a trained rater
who was unaware of diagnosis and all other data. Dimensions of so-
cial skills scored include ﬂuency, clarity, focus, negotiation ability,
persistence, and social appropriateness. Raters were trained to the
gold standard ratings of the instrument developers (ICC = .86) and
high interrater reliability was maintained at 3 months (ICC = .87).
The mean of the ratings on these variables across the two measures
was used in this study.2.2.4. Real world functional performance
The Speciﬁc Level of Function Scale (Schneider & Struening, 1983)
is a 43-item observer-rated scale that provides a report of behavior
and real world functioning; the two speciﬁc domains examined in
this study included the Interpersonal (e.g., initiating, accepting, and
maintaining social contacts), and Activities (e.g., paying bills, use of
leisure time, use of public transportation) subscales.
Ratings by a high contact clinician, who indicated that they knew
the patient at least “very well” on the SLOF 5-point Likert scale, were
made based on the amount of assistance required to perform real
world skills or frequency of the behavior. SLOF raters were in a posi-
tion to observe behavior in the community, and were unaware of per-
formance on any other measures.
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Hierarchical regression analyses determined whether functional
competence accounted for a signiﬁcant proportion of variance be-
yond that accounted for by symptoms, when predicting functional
performance. The severity of positive, negative, and depressive
symptoms was used in these analyses, and was calculated as the
mean rating of the PANSS items used to create the symptom catego-
ries outlined below. Symptoms were always entered into the ﬁrst
block, and the measure of functional competence was entered in
the second block.
We also conducted moderated regression analyses using symptom
group as a categorical moderator. We were interested in moderation
analyses that would address the clinical issue of symptom presence or
remission and we selected those items that the APA remission work-
ing group viewed as central features of the illness and relevant to re-
mission from symptoms.
The presence of positive symptoms was deﬁned as a score of 4 or
greater (indicating a moderate level of symptom) on at least one of
the following core items on the PANSS positive symptoms domain:
Delusions, Conceptual Disorganization, or Hallucinations. The pres-
ence of negative symptoms was deﬁned as a score of 4 or greater on
at least one of the following PANSS items: Blunted Affect, Emotional
Withdrawal, Social Withdrawal, or Disturbance of Volition. Absence
of the symptoms was deﬁned as a score of less than 4 (indicating
that symptom is either entirely absent, or that the symptom is ques-
tionable or minor). We did not include other variables because of
their poor loading on positive and negative symptom factors (e.g.,
White et al, 1997). The presence of depressive symptoms was deﬁned
as a BDI score greater than or equal to 11, a clinical cutoff that indi-
cates at least a mild level of depressive symptoms (Beck et al., 1988).
Participants were classiﬁed into groups according to their pri-
mary type of symptom: positive, negative, depressive, or
undifferentiated. The positive group had positive symptoms with
minimal negative symptoms; the negative group had negative
symptoms with minimal positive symptoms; the depressive group
had depressive symptoms with minimal positive or negative symp-
toms; and the undifferentiated group could not be classiﬁed into
one of the above categories. Demographic information is included
in Table 1.
3. Results
3.1. Relationship between negative and depressive symptoms
Given the conceptual overlap between some negative and depres-
sive symptoms, we calculated Spearman's rank correlations to deter-
mine whether any of the negative symptoms were correlated
signiﬁcantly with the severity of depressive symptoms. Total BDITable 1
Demographic information by group.
Positive symptoms
(n = 26)
Negative symptoms
(n = 17)
Diagnosis
(Schizophrenia: Schizoaffective)
22:4 12:5
Gender
(men:women)
17:9 13:4
Age
Mean (SD)
55.2 (13.4) 57.3 (10.8)
Years of education
Mean (SD)
12.5 (3.1) 12.7 (1.7)
Age at ﬁrst hospitalization
Mean (SD)
24.4 (10.5) 24.8 (14.3)
Independent livinga % 69.6% 64.3%
a Living independently in the community without supervision.score was not associated with blunted affect, emotional withdrawal,
or disturbance of volition, ps N .313, but was signiﬁcantly, but mini-
mally, correlated with the negative symptom category of passive/ap-
athetic social withdrawal, r = .21, p = .019.
We also conducted non-parametric analyses to determine wheth-
er having depressive symptoms was associated with having negative
symptoms, according to our criteria. There was no signiﬁcant associ-
ation, Cramer's V = 0.095, p = .286, indicating that negative and de-
pressive symptoms, as measured in the present study, are generally
distinct constructs. A weak association was observed between the
presence of negative symptoms and the presence of positive symp-
toms, Cramer's V = .234, p = .008.
3.2. Hierarchical regression models
Results of the hierarchical regression analyses are presented in
Table 2. No symptoms signiﬁcantly predicted SLOF Activities, and in
all models, scores on the UPSA accounted for a signiﬁcant proportion
of variance beyond that accounted for by symptoms. Only negative
symptoms signiﬁcantly predicted the SLOF Interpersonal domain,
and in all models, SSPA accounted for a signiﬁcant proportion of var-
iance beyond that accounted for by symptoms.
3.3. Moderated regression analyses
All continuous independent variables were centered at the mean
before being entered into the regression equation in order to reduce
multicollinearity. The categorical variable of primary symptom type
was dummy coded such that one variable represented the compari-
son between the positive symptom group and depressive symptom
group, one variable represented the comparison between the nega-
tive symptom group and depressive symptom group, and the other
variable represented the comparison between the undifferentiated
group and the depressive symptom group.
3.3.1. Cognition predicting functional capacity/performance
The neurocognition composite score at baseline signiﬁcantly
predicted the UPSA scores at 18 month follow-up such that better
neurocognition was associated with better performance on the
UPSA, B = 4.56, t = 7.74, p b .001. Baseline neurocognition was
also a signiﬁcant predictor of SLOF Activities at 18 month follow-up,
B = 5.91, t = 4.14, p b .001.
There was no signiﬁcant moderating effect of symptoms on the re-
lationship between the neurocognitive composite score at baseline
and UPSA at 18 month follow-up, ps N .191. There was also no signif-
icant moderating effect of symptoms on the relationship between
cognition at baseline and SLOF Activities at 18 month follow-up,
ps N .091.Depressive symptoms
(n = 25)
Undifferentiated symptoms
(n = 68)
Test statistic p
13:12 56:12 χ2 = 10.6 .014
18:7 52:16 χ2 = 1.3 .73
54.2 (6.2) 57.6 (6.5) F = 1.15 .333
13.0 (3.4) 13.0 (2.05) F = .304 .822
34.5 (11.2) 25.4 (9.2) F = 4.77 .004
72.0% 66.1% χ2 = .393 .942
Table 2
Hierarchical regression results using symptoms as continuous variables. Symptom var-
iable was entered into the ﬁrst block and functional competence measure was entered
into the second block.
Model R R2 Change p
SLOF Activities Positive symptoms .047 .002 .594
Positive symptoms, UPSA .226 .051 .011
Negative symptoms .131 .017 .135
Negative symptoms, UPSA .277 .059 .005
Depressive symptoms .039 .002 .659
Depressive symptoms, UPSA .229 .051 .010
SLOF Interpersonal Positive symptoms .107 .011 .225
Positive symptoms, SSPA .298 .078 .001
Negative symptoms .344 .118 b .001
Negative symptoms, SSPA .419 .057 .004
Depressive symptoms .066 .004 .462
Depressive symptoms, SSPA .275 .071 .002
Bolded values indicate a signiﬁcant (p b .05) increase in the variance accounted for by
the current block compared to the prior block.
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There was a signiﬁcant moderating effect of symptoms on the re-
lationship between UPSA at baseline and SLOF Activities at 18 month
follow-up such that the relationship was greater for individuals
with primarily positive symptoms, B = 1.15, F(1,128) = 10.06,
p = .002, and individuals with undifferentiated symptoms, B = 0.74,
F(1,128) = 6.71, p = .01, compared to individuals with only depres-
sive symptoms. There was no difference in the magnitude of this rela-
tionship between individuals with primarily negative symptoms and
individuals with only depressive symptoms, p = .824.
Simple slopes follow-ups were conducted to determine for which
symptom subgroups baseline UPSA predicted SLOF Activities at
18 months (Fig. 1). Baseline UPSA signiﬁcantly predicted SLOF Activ-
ities at 18 months for individuals with primarily positive symptoms,
B = 1.19, F(1,128) = 12.50, p = .001, 95% CI = .52–1.86, and indi-
viduals with undifferentiated symptoms, B = 0.78, F(1,128) = 9.58,
p = .002, 95% CI = .28–1.28, but not for individuals with primarily
negative symptoms, B = -.13, F(1,128) = 0.03, p = .864, 95%
CI = −1.61 to 1.4, or primarily depressive symptoms, B = .04,
F(1,128) = .095, p = .759, 95% CI = − .22 to .31.
We calculated a regression model using SSPA at baseline to pre-
dict the SLOF Interpersonal subdomain at 18 month follow-up.
There was a signiﬁcant moderating effect of symptoms on this rela-
tionship such that the relationship was stronger for individuals
with primarily positive symptoms compared to individuals with
only depressive symptoms, B = 4.59, F(1,124) = 6.67, p = .011.
There was no difference in the magnitude of this relationship be-
tween individuals with primarily negative symptoms, p = .869, orFig. 1. Prediction of SLOF (activities in the community) at 18 month follow-up by UPSA
(adaptive competence) at baseline, by symptom group.individuals with undifferentiated symptoms, p = .190, and individ-
uals with only depressive symptoms.
Simple slopes follow-ups (Fig. 2) revealed that SSPA score at
baseline signiﬁcantly predicted SLOF Interpersonal functioning at
18 month follow-up for individuals with primarily positive symptoms,
B = 4.31, F(1,124) = 13.96, p b .001, 95% CI = 2.03–6.59, and for
individuals with undifferentiated symptoms, B = 1.81, F(1,124) =
4.78, p = .031, 95% CI = 0.17–3.44. This same relationship did not
exist for individuals with primarily negative symptoms, B = 0.19,
F(1,124) = 0.01 p = .940, 95% CI = −4.77 to 5.14, or only depres-
sive symptoms, B = −0.28, F(1,124) = .043, p = .836, 95%CI = −2.96
to 2.40.
The same patterns of results were found even after controlling for
diagnosis, age, gender, education, age at ﬁrst hospitalization, and in-
dependent living status.4. Discussion
Results from this study suggest that speciﬁc classes of prominent
symptomsmoderate the relationship between functional competence
at baseline and functional performance at an 18 month follow-up for
both adaptive and interpersonal functioning in individuals with
schizophrenia. No moderation was observed for the relationship be-
tween neurocognition and capacity or performance. A relationship
existed between competence and performance for individuals with
primarily positive symptoms and undifferentiated symptoms, such
that greater competence in an optimized assessment setting was as-
sociated with better future real world performance. No signiﬁcant re-
lationship was found between baseline competence and real world
performance 18 months later for individuals with primarily negative
or primarily depressive symptoms.
Many individuals with schizophrenia will experience remission of
their positive symptoms, but may not function within normal societal
expectations. It is well recognized that these individuals with schizo-
phrenia may continue to experience persistent negative symptoms
(Buchanan, 2007; Pogue-Geile & Harrow, 1985). Although the impor-
tance of these residual negative symptoms in limiting functional re-
covery is being recognized, and treatments have been developed to
target these symptoms, there is little research examining the role of
residual depressive symptoms in schizophrenia. Our results suggest
that for individuals who are in remission from positive symptoms, de-
pressive symptoms have the potential to impair functional recovery
in a similar way as negative symptoms. Furthermore, residual depres-
sive symptoms were found to be independent of residual negative
symptoms, indicating that although they are distinct constructs, asFig. 2. Prediction of SLOF Interpersonal domain (interpersonal performance) at 18 month
follow-up by SSPA (interpersonal competence) at baseline, by symptom group.
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as persistent symptoms that require treatment.
This study has several limitations that should be taken into con-
sideration, some of which may limit the generalizability of these ﬁnd-
ings to other samples. This study features the performance of older
patients with a long-term course of illness and may not generalize
to performance of younger or more acutely ill individuals. The criteria
used to classify individuals into positive and negative symptoms
groups were based on the PANSS – a semi-structured interview,
whereas the criterion for the presence of depressive symptoms was
based on the BDI – a self-report questionnaire. Self-report question-
naires can suffer from validity issues and using a self-report measure
of depression may have decreased the validity of the depressive
symptommeasurement compared to the negative and positive symp-
tom measurements. Our sample size per group was relatively small,
potentially leaving us underpowered to detect signiﬁcant correlations
within some groups. However, we used moderation analyses to ex-
amine differences in relationships between groups, increasing our
power to detect these effects. We also acknowledge that the SLOF
does not contain identical items to the UPSA or SSPA, and therefore
some of the discrepancy observed may be the result of differences
in content, however, it is unlikely that item differences can fully ac-
count for the varying relationships found among the symptom classi-
ﬁcations. Lastly, although real-world observation may be the ideal
way to measure functioning, this method still relies on third-party re-
ports which may not be accurate representations of behavior across
diverse situations (Pyne et al., 2003), might not be available to all per-
sons, and can be confounded if the participant knows they are being
observed (Robson, 2002).
As our treatment target for individuals with schizophrenia shifts
from remission of positive symptoms towards achieving functional
recovery, understanding how residual negative and depressive symp-
toms impair functioning is increasingly important. Incorporating
treatment for residual depressive symptoms into chronic care and
early intervention programs may be a mechanism through which
we can improve such independent community functioning. Our ﬁnd-
ings suggest that both residual depressive symptoms and residual
negative symptoms impede an individual's ability to apply the func-
tional skills they possess in the real world more than positive symp-
toms, and are essential treatment targets in our goal to promote
functional recovery.
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